Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - ronald+castellano
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Anticancer Agents for Triple-Negative Breast Cancers
Selectively Kills EGFR+, HER2+, and HER+3 Tumors via New Mechanism, Enabling These Tumors to Overcome Resistance to Current TherapyThis first-in-class compound selectively kills cancer cells without harming normal tissues. The Epidermal Growth Factor Receptor (EGFR) family members -- EGFR, Human Epidermal Growth Factor Receptor-2 (HER2) and Human Epidermal...
Published: 11/19/2021
|
Inventor(s):
Brian Law
,
Ronald Castellano
Keywords(s):
Akt
,
breast cancer
,
Compound
,
EGFR
,
Her2
,
HER2/neu receptor
,
Therapeutic
Category(s):
Technology Classifications > Human Health Care > Therapeutics